Key result
Postnatal shift to fatty acid oxidation supplies ~85% of cardiac ATP but arrests cardiomyocyte proliferation.
Why the study?
Adult myocardium has limited regenerative capacity after ischemic injury because cardiomyocytes rapidly lose their proliferative capacity postnatally, a decline closely linked to perinatal metabolic shifts.
Synthesizes preclinical evidence demonstrating that reversing the postnatal metabolic switch from fatty acid oxidation back to glycolysis can reactivate cardiomyocyte proliferation and promote myocardial regeneration after ischemic injury.
Answers are grounded in this paper and cite their sources.
Metabolic reversal of the postnatal switch merits targeted study; leaves open safe translation to regeneration after human ischemic injury.
Cardiovascular disease is the leading cause of mortality worldwide. Myocardial injury resulting from ischemia can be fatal because of the limited regenerative capacity of adult myocardium. Mammalian cardiomyocytes rapidly lose their proliferative capacities, with only a small fraction of adult myocardium remaining proliferative, which is insufficient to support post-injury recovery. Recent investigations have revealed that this decline in myocardial proliferative capacity is closely linked to perinatal metabolic shifts. Predominantly glycolytic fetal myocardial metabolism transitions towards mitochondrial fatty acid oxidation postnatally, which not only enables efficient production of ATP but also causes a dramatic reduction in cardiomyocyte proliferative capacity. Extensive research has elucidated the mechanisms behind this metabolic shift, as well as methods to modulate these metabolic pathways. Some of these methods have been successfully applied to enhance metabolic reprogramming and myocardial regeneration. This review discusses recently acquired insights into the interplay between metabolism and myocardial proliferation, emphasizing postnatal metabolic transitions.
No takes yet. Share an insight, caveat, or question.
Sada et al. (2024) conducted a review in Myocardial injury, ischemic heart disease, and postnatal loss of cardiac regenerative capacity. Metabolic reprogramming and modulation of postnatal metabolic shifts (e.g., inhibiting fatty acid oxidation, enhancing glycolysis, hypoxia exposure) was evaluated on Cardiomyocyte proliferation and myocardial regeneration. Postnatal shifts from glycolysis to mitochondrial fatty acid oxidation supply up to 85% of adult cardiac ATP but drive cardiomyocyte cell cycle arrest via ROS and epigenetic changes.
Synapse has enriched 10 related papers. Consider them for comparative context: